Navigation Links
Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
Date:3/31/2011

PARSIPPANY, N.J., March 31, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX), an emerging specialty pharmaceutical company, today announced financial results for the fourth quarter and full-year ended December 31, 2010, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL™ and established 2011 financial guidance.

"Since our initial public offering in February, we have continued to make significant progress in educating healthcare professionals and other decision makers on the advantages of EXPAREL, including multiple recent data presentations at medical meetings and the formation of several clinical advisory boards led by key opinion leaders," said David Stack, president and chief executive officer of Pacira Pharmaceuticals, Inc.  "We have received encouraging feedback from these health care providers regarding the need for a safe, long-acting, easy to use analgesic to manage postsurgical pain. As we continue to advance our pre-launch strategy, we are planning to conduct a number of health outcomes studies focused on the potential for EXPAREL to control pain with reduced reliance on opioid (morphine) analgesics.  The health outcomes program is designed in collaboration with our acute health care customers in order to define postsurgical patient and procedure needs where reduced opioid (morphine) consumption provides the opportunity for enhanced patient care and hospital economics." 

Financial Highlights

  • Net loss for the quarter ended December 31, 2010 was $7.0 million, or $12.27 per share, compared with $9.0 million, or $15.63 per share, for the quarter ended December 31, 2009. Net loss for the year ended December 31, 2010 was $27.1 million, or $47.29 per share, compared with $31.7 million, or $55.32 per common share, for the year ended December 31, 2009.  In February 2
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    2. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    3. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    4. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    6. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    7. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    8. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
    9. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
    10. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
    11. Cempra Pharmaceuticals to Present at Two Upcoming Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... , July 31, 2014 For its ... California , Art,s-Way Scientific has earned a ... With competition in over 30 categories, MBI,s contest ... MBI members, which include building manufacturers, dealers, and product ... an excellent example the capability of our team," said ...
    (Date:7/31/2014)... LONDON , July 31, 2014 ... for the medical industries, announced today the incorporation of genae UK ... United Kingdom has one of the largest medical device ... in 2012 and it is projected to increase by a CAGR ... billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, ...
    (Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
    Breaking Medicine Technology:Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
    ... 15 The U.S. Food and Drug Administration (FDA), ... Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered ... responsibility for criminal actions including distribution of an unapproved ... of an FDA inspection. (Logo:   ...
    ... 15 New England Biolabs (NEB) has announced ... of $1.22 million to fund the research and ... (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b) (Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b) ... developing tools that advance epigenetics research and discovery, ...
    Cached Medicine Technology:Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 2Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 3New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies 2
    (Date:7/31/2014)... A program for anyone looking to ... University of Colorado Anschutz Health and Wellness Center ... camp and transformation program. , “Extreme Weight Loss: ... USA, is an evidenced-based program inspired by the unscripted ... USA. This season, the show has participants spending their ...
    (Date:7/31/2014)... CA (PRWEB) July 31, 2014 Dr. ... closure in front of an enthusiastic audience of international ... Trichophytic Closure improves the appearance of a patient’s ... results of this procedure are minimally detectable in most ... technique improves on the original method of donor wound ...
    (Date:7/31/2014)... July 31, 2014 You’re having a wonderful ... have you suddenly developed chills and fever, headache, stiff neck, ... suspect a flu-like illness, it could actually be the first ... risk of developing Lyme is greater than you might think. ... cases occurred in the U.S. annually. But the Centers for ...
    (Date:7/31/2014)... (PRWEB) July 31, 2014 According to ... Business Journal , Endo International, one of several manufacturing ... thousands of transvaginal claims for $830 million (in re: ... Litigation (MDL No. 2325). Melinda Helbock, Founder of The ... agrees with the settlement and is pleased to see ...
    (Date:7/31/2014)... LDM Global ( http://www.ldmglobal.com ) announces ... is simplified and predictable with fixed fees across the ... leading international provider of legal discovery management services for ... glaringly apparent that both the courts and legal counsel ... the complex pricing structure that plagues the litigation support ...
    Breaking Medicine News(10 mins):Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3Health News:Novel Technique in Wound Closure Delivers More Discreet Results in Hair Transplant Patients 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3Health News:San Diego Product Liability Firm Provides Commentary on the Latest Developments in Transvaginal Mesh Litigation 2Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2
    ... Medical Manager and Misys Customers Get Discount to Switch ... ... 2008 -- CollaborateMD, a leading provider of Internet practice management ... industry, announced today an upgrade program for existing users of ...
    ... Calif., Aug. 13 Watson,Pharmaceuticals, Inc. (NYSE: ... that the United States District Court for the,Southern ... Sodium ER,tablets, the generic version of Naprelan(R), infringes ... action, Elan Corporation Plc v.,Andrx Pharmaceuticals, Inc., was ...
    ... Things are getting even rosier for,MGM Consumer ... that actress Emmy Rossum has signed on as ... as,Bulma in the upcoming feature film "Dragonball," and ... daughter), "The Phantom of the Opera" (as,Christine) and ...
    ... donations for breast cancer,research/programs, DETROIT, Aug. 13 ... part to end cancer, as well as honor the ... goal of walking 18,marathons in 18 days -- The ... cancer research and programs at the Barbara Ann Karmanos ...
    ... Olympics focuses attention on health problems outside the lungs, ... Air pollution has short-term and long-term toxic effects on ... cardiac illness, and even cause death, a new report ... in the Aug. 26 issue of the Journal ...
    ... Cutting-Edge Patient Safety ... ... with Kahala Nui, a Life Care Retirement Community in Honolulu,Hawai,i, to ... Care Center. Kahala Nui joins a list of,progressive healthcare facilities by ...
    Cached Medicine News:Health News:CollaborateMD Offers Upgrade Program to Competitors' Users 2Health News:Watson Announces District Court Ruling in Naproxen Sodium Patent Suit 2Health News:Watson Announces District Court Ruling in Naproxen Sodium Patent Suit 3Health News:Actress Emmy Rossum to Act as Official Spokesperson of PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 2Health News:Actress Emmy Rossum to Act as Official Spokesperson of PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 3Health News:More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius 2Health News:More Than 400-mile Victory Walk to Conclude Aug. 14, at Campus Martius 3Health News:Air Pollution Can Damage Heart, Blood Vessels, Too 2Health News:Hoana Medical, Inc. Partners With Kahala Nui to Improve Patient Safety 2Health News:Hoana Medical, Inc. Partners With Kahala Nui to Improve Patient Safety 3Health News:Hoana Medical, Inc. Partners With Kahala Nui to Improve Patient Safety 4
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: